Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.
Rampino
M
M
Department of Medical and Surgical Sciences, Radiation Oncology Unit, University of Torino, S. Giovanni Battista Hospital, Torino, Italy. mrampino@molinette.piemonte.it
Ricardi
U
U
Munoz
F
F
Reali
A
A
Barone
C
C
Musu
A R
AR
Balcet
V
V
Franco
P
P
Grillo
R
R
Bustreo
S
S
Pecorari
G
G
Cavalot
A
A
Garzino Demo
P
P
Ciuffreda
L
L
Ragona
R
R
Schena
M
M
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D018307:Neoplasms, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011446:Prospective Studies; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D000077195:Squamous Cell Carcinoma of Head and Neck; D016896:Treatment Outcome; D055815:Young Adult
D000970:Antineoplastic Agents; D002945:Cisplatin